
Phytopharmaceuticals and Herbal Drugs
Prospects and Safety Issues in the Delivery of Natural Products
- 1st Edition - July 15, 2023
- Imprint: Academic Press
- Editors: Manju Rawat Singh, Deependra Singh
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 9 9 1 2 5 - 4
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 9 3 6 9 - 2
Phytopharmaceuticals and Herbal Drugs: Prospects and Safety Issues in the Delivery of Natural Products explores the delivery aspects of plant-based drugs, providing insights… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quotePhytopharmaceuticals and Herbal Drugs: Prospects and Safety Issues in the Delivery of Natural Products explores the delivery aspects of plant-based drugs, providing insights into formulation constraints associated with plant-based drugs, the development of novel delivery systems based on polymers or lipids, and how combining natural products with technological advancements in drug delivery is making large strides. Some of the best-selling drugs for the treatment of diseases like cancer, ulcers and malaria are either natural products or their derivatives, all of which are covered in this comprehensive resource.
This book will be useful to researchers working in plant-derived medicines and the development of their delivery systems, including sections on their derivatives and analogs that represent over 50% of all drugs in clinical use. Active ingredients originated from plant resources generally exhibit compromised desired effects limited by issues such as stability, solubility, molecular size, bioavailability and toxicity.
- Includes perspectives from academic and industry research
- Provides information on the safety, regulatory aspects and clinical aspects related to plant-based drugs
- Introduces developments of new targeted drug delivery systems
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- Contributors
- About the editors
- Preface
- Acknowledgments
- Section I. Prospects of plant-based therapeutics
- Chapter 1. Plant-based therapeutics: current status and future perspectives
- 1. Introduction
- 2. Phytopharmaceuticals: revival of traditional medicine in a modern way
- 3. Research in natural products
- 4. The market trend regarding natural product
- 5. Future perspectives
- 6. Conclusion
- Chapter 2. Worldwide health scenario from the perspective of herbal medicine research
- 1. Introduction
- 2. Herbal drugs
- 3. Application of phytomedicine
- 4. Research efforts on herbal medicine
- 5. Safety and efficacy of herbal drugs
- 6. Conclusion and future prospects
- Section II. Challenges and delivery aspects of phytomedicines and bioactives
- Chapter 3. Challenges in delivery of plant actives
- 1. Natural compounds with therapeutic potential
- 2. Plant bioactives market and conventional pharmaceutical formulations
- 3. Limitations of plant bioactives
- 4. Innovative pharmaceutical formulations of plant bioactives
- 5. Nanotechnology as key strategy to deliver bioactives
- 6. Screening models for formulation development
- 7. Regulatory framework of isolated compounds from plants, extracts, or plant-derived products
- 8. Conclusions and future perspectives
- Chapter 4. Lipid-based particulate systems for delivery of plant actives and extracts: Extraction, prospective carriers, and safety issues
- 1. Introduction
- 2. Issues related to the extraction of herbs and their safety
- 3. Lipid-based systems
- 4. Lipid-based system as carriers for plant actives and extracts
- 5. Conclusion
- Chapter 5. Phyto-complexed systems as a versatile tool for the delivery of plant-based drugs
- 1. Introduction
- 2. Complexation
- 3. Methods for the preparation of phyto-complexes
- 4. Characterization of complexes
- 5. Applications
- 6. Conclusion
- Chapter 6. Impact of nanotechnology on herbal bioactives: an overview
- 1. Introduction
- 2. Bioactivities of polyphenols
- 3. Hiccups for the efficient delivery of phytoconstituents/bioactives
- 4. Nanotechnology: Importance and application
- 5. Nanophytomedicines: Nanostructured drug delivery systems for bioactive
- 6. Understanding herbal nanoparticles
- 7. Conclusions
- Chapter 7. Application of nanomedicine for efficient delivery of herbal bioactives
- 1. Introduction
- 2. Herbal bioactive compounds
- 3. Nanocarriers for control drug delivery
- 4. Conclusion and future prospects
- Chapter 8. Nanophytomedicine: nanotechnology for herbal product development and value addition
- 1. Introduction
- 2. Phytomedicines
- 3. Nanotechnology-based herbal product development and value addition
- 4. Nanophytomedicines
- 5. Conclusion
- Section III. Safety considerations, regulatory, and commercial aspects
- Chapter 9. Phytopharmaceuticals and herbal drugs: prospects and safety issues in the delivery of natural products
- 1. Introduction
- 2. Safety issues
- 3. Role of novel delivery systems in overcoming some of these challenges
- 4. Storage and stability issues
- 5. Regulatory aspects
- 6. Concluding remarks and future prospects
- Chapter 10. Herbal drug interaction and effects on phytopharmaceuticals
- 1. Introduction
- 2. Types of herb-drug interactions
- 3. Pharmacokinetic of herb-drug interaction
- 4. Pharmacodynamic of herb-drug interaction
- 5. Reasons and need of herb-drug interaction
- 6. How herbs interact with coadministered allopathic drugs
- 7. Enzymes responsible for herb-drug interaction
- 8. Mechanism of herb-drug interaction
- 9. Examples of herb-drug interaction
- 10. Conclusion
- Chapter 11. Clinical, ethical, and regulatory issues of botanicals
- 1. Introduction
- 2. Need for regulation of botanicals
- 3. Clinical issues of botanicals
- 4. Ethical issues of botanicals
- 5. Regulatory issues of botanicals
- 6. Conclusion and future perspectives
- Chapter 12. Commercial aspect and market potential of phytoactive products
- 1. Introduction
- 2. Health benefits of phytochemicals
- 3. Phytochemicals from plant to market
- 4. Classification of phytochemicals
- 5. Phenolic compounds
- 6. Carotenoids
- 7. Alkaloids
- 8. Nitrogen-containing compounds
- 9. Organosulfur compounds
- 10. Contemporary scenario and market demand of phytochemicals
- 11. Market potential of phytochemicals and phytoconstituents
- 12. Worldwide demands of phytochemicals
- 13. Segments of phytochemical global market
- 14. Other sector
- 15. International key players
- 16. Kemin industries Inc.
- 17. Naturex
- 18. Badische Anilin-und SodaFabrik
- 19. Organic herb Inc.
- 20. Chengdu biopurify phytochemicals Ltd.
- 21. Nektium
- 22. Demand in Indian market
- 23. Sydler
- 24. Alkaloids corporation
- 25. Kothari phytochemicals international
- 26. Conclusion
- Section IV. Application aspects of phytopharmaceuticals
- Chapter 13. Interactions between radiopharmaceutical products and herbal medicines
- List of symbols and abbreviations
- 1. Introduction
- 2. Radiopharmaceuticals
- 3. Discussion and conclusion
- Chapter 14. Use of microfluidic organ-on-a-chip systems for the screening and development of phytopharmaceuticals and herbal drugs
- 1. Introduction
- 2. Phytochemicals and herbal phytopharmaceuticals
- 3. Organ-on-a-chip systems
- 4. Herbochip
- 5. Current challenges and future directions
- 6. Conclusion
- Chapter 15. New and revisited approaches on the transdermal delivery of polyphenols-loaded nanoparticles for melanoma prevention and treatment
- List of abbreviations and acronyms
- 1. Introduction
- 2. Skin: anatomy and physiology
- 3. Melanoma: pathophysiology and therapeutic approaches
- 4. Conclusion and future perspectives
- Chapter 16. Novel drug delivery approaches for improving therapeutic applications of berberine and berberine-rich herbal preparations
- 1. Introduction
- 2. Characteristics of BER
- 3. Delivery approaches
- 4. Conclusion
- Chapter 17. Impact of phytomedicines and their novel delivery systems as an alternative for the treatment of neurodegenerative disorders
- 1. Introduction
- 2. Phytomedicines for neurodegenerative disorders (NDs): A neuropharmacological perspective
- 3. Delivery system for phytoconstituents to the CNS
- 4. Nanocarriers-based delivery of phytoconstituents for NDs
- 5. Conclusion
- Chapter 18. Role of phytopharmaceuticals in inflammatory disorders
- 1. Introduction
- 2. Antiinflammatory phytochemicals
- 3. Phytopharmaceuticals regulate inflammatory markers and thus boost immunity to alleviate COVID-19 (SARS-CoV-2)
- 4. Resveratrol
- 5. Curcumin
- 6. Quercetin
- 7. Genistein
- 8. Butyrate
- 9. Licorice
- 10. Proanthocyanidins (PAC)
- 11. Bromelain
- 12. Naringenin
- 13. Naringin
- 14. Chrysin
- 15. Mangiferin
- 16. Conclusion
- Index
- Edition: 1
- Published: July 15, 2023
- Imprint: Academic Press
- No. of pages: 520
- Language: English
- Paperback ISBN: 9780323991254
- eBook ISBN: 9780323993692
MS
Manju Rawat Singh
DS